In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to ...
ABC7 KABC on MSN
UCI Health launches promising clinical trial using CAR T-cell therapy to treat lupus
A promising clinical trial underway at UCI Health is aimed at helping patients achieve long-term remission.
Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...
While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...
Researchers from Tr1x Inc. presented the development of TRX-319, a novel allogeneic regulatory T-cell therapy designed for the treatment of autoimmune disorders.
Autoimmune skin diseases, characterized by the immune system mistakenly attacking specific skin cells, show high clinical heterogeneity and a ...
Researchers have proposed a novel integrated framework to understand the complex progression of autoimmune skin diseases. A ...
Three years after enrolling its first patients, a consortium of researchers examining the growing issue of immune-related adverse events due to immune checkpoint inhibitor cancer therapy released a ...
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript February 5, 2026 Adaptive Biotechnologies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results